Behzad Aghazadeh Insider Profile
4 Followers
Behzad Aghazadeh, Director, See Remarks, Ten Percent Owner at Scribe Therapeutics Inc., holds 3.09M shares in Scribe Therapeutics Inc. (Ticker: SCTX), holds 3.47M shares in Whitehawk Therapeutics (Ticker: WHWK), holds 0.00 shares in Immunomedics (Ticker: IMMU). Most recently, Behzad Aghazadeh Bought ― shares of Scribe Therapeutics Inc. on Jul 28, 2026 for an estimated value of $36.26M.
Behzad Aghazadeh Scribe Therapeutics Inc. (SCTX)Director, See Remarks, Ten Percent Owner
Scribe Therapeutics Inc. (SCTX)
Director, See Remarks, Ten Percent Owner
Ranked #30,852 out of 108,921 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+64.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Behzad Aghazadeh holds in companies
Most Profitable Insider Trade
Stock:
Immunomedics
(IMMU)
(IMMU)
Rating:Informative Buy
Date:Nov 15, 2017 - Nov 15, 2018
Return:+70.30%
The most profitable trade made by Behzad Aghazadeh
Behzad Aghazadeh's Trading History
Scribe Therapeutics Inc.
Jul 28, 2026
Director, See Remarks, Ten Percent Owner
Informative Buy
36.26M
$88.56M
Immunomedics
Oct 23, 2020
―
Uninformative Sell
―
$0.00
Whitehawk Therapeutics
Sep 26, 2022
Director, See remarks, Ten Percent Owner
Uninformative Buy
15.75M
$15.97M
List of latest transactions for each holding click on a transaction to see Behzad Aghazadeh's performance on stock
You May Also Like
Behzad Aghazadeh insider profile FAQ
What is the percentage of profitable transactions made by Behzad Aghazadeh?
The percentage of profitable transactions made by Behzad Aghazadeh is 100%.
What is the average return per transaction made by Behzad Aghazadeh?
The average return per transaction made by Behzad Aghazadeh is 64.50%.
What stocks does Behzad Aghazadeh hold?
Behzad Aghazadeh holds: SCTX, IMMU, WHWK stocks.
What was Behzad Aghazadeh’s latest transaction?
Behzad Aghazadeh latest transaction was an Informative Buy of $36.26M.
What was Behzad Aghazadeh's most profitable transaction?
Behzad Aghazadeh’s most profitable transaction was an Informative Buy of IMMU stock on November 15, 2017. The return on the trade was 70.30%.
What is Behzad Aghazadeh's role in Scribe Therapeutics Inc.?
Behzad Aghazadeh's role in Scribe Therapeutics Inc. is Director, See Remarks, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.